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Renal fibroblast-like cells in Goodpasture syndrome rats. activated resident renal cells, and Fbs themselves to pro-
Background. The extent of renal fibrosis is the best predictor duce extracellular matrix (ECM) molecules and to popu-
for functional outcomes in a variety of progressive renal dis- late such interstitial areas in parallel with the atrophy
eases. Interstitial fibroblast-like cells (FbLCs) are presumably and the loss of normal integrity to generate a classicalinvolved in the fibrotic process. However, such FbLCs have
form of fibrosis [1–3].never been well characterized in the kidney.
In contrast to the well-characterized cellular compo-Methods. We characterized renal FbLCs in the nephritic
kidney (in which the number of FbLCs and extracellular matrix nents within the interstitium of healthy kidneys, for ex-
accumulation were significantly increased) with regards to their ample, Fbs and lipid-laden interstitial cells (type I inter-
expression of phenotypic and functional markers using day 49 stitial cells), macrophages (type II interstitial cells), and
Goodpasture syndrome (GPS) rats. dendritic cells [7], these components in the nephritic kidneyResults. Within the renal cortical interstitium, there were a
still require further morphological and functional investi-number of -smooth muscle actin (-SMA) FbLCs, negative
gation. Fibroblasts are not homogeneous and consist offor vimentin (VIM) and transforming growth factor-1, and
not equipped with well-developed rough endoplasmic reticu- a variety of functionally different interstitial cells called
lum and actin-stress fibers. All of these findings were incompati- fibroblast-like cells (FbLCs) in a given interstitium [8, 9].
ble with the typical features of granulation tissue -SMA Especially in a diseased interstitium, Fbs are thought to be
myofibroblasts. On the other hand, FbLCs negative for -SMA highly heterogeneous, but this remains to be characterized.
and VIM produced 1(I) procollagen in the nephritic kidney.
Among them, only granulation tissue Fbs termed myofi-Conclusion. A number of FbLC populations reside within
broblasts (myoFbs) in the skin have been intensively in-the cortical interstitium of the kidney in GPS rats, each of
vestigated because of their readily available muscle-re-which is likely to have developed independently in response
to the local conditions of the nephritic kidney, contributing to lated phenotypic markers, for example, -smooth muscle
renal fibrogenesis. Further studies are needed to clarify the actin (-SMA), vimentin (VIM), desmin (DSM), and my-
key type of FbLC that orchestrates other members to produce osin heavy chain (MYS) [9, 10]. Most investigators inter-
renal fibrosis. ested in organ fibrosis have focused on -SMA FbLCs
as presumed myoFbs in any given organ, and they seem
to pay little attention to the heterogeneity of -SMA
Renal fibrosis is a final common pathway through FbLCs within different organs. However, even the origin
which most chronic renal diseases progress to end-stage of -SMA FbLCs has remained largely undetermined
renal failure [1–4]. It has long been noted in the various in most organs, despite the considerable number of pro-
types of glomerular disease that the degree of renal inter- posed candidates, for example, Fbs, vascular smooth mus-
stitial alteration correlated better than glomerular dam- cle cells, vascular pericytes, tubular epithelium, endothe-
age itself with renal function at the time of biopsy and lial cells, monocytes, etc. [9–17]. In addition, the exact
with the prognosis of the disease [5, 6]. Interstitial alter- contribution of -SMA FbLCs to fibrogenesis still re-
quires confirmation, especially within the kidney [1–4,ations in the nephritic kidney consist of infiltrating im-
13, 18–21]. In this study, in order to characterize renalmune cells, atrophic tubules, and fibrosis. Fibroblasts (Fbs)
FbLCs within a diseased interstitium, we determinedare thought to be stimulated by infiltrating immune cells,
the in vivo phenotype and cell biology of FbLCs in the
nephritic kidney of Goodpasture syndrome (GPS) rats.
Key words: renal fibrosis, fibroblasts, myofibroblasts, -smooth muscle
actin, vimentin, 1(I)procollagen.
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ration and characterization of GPS rats have been pre- Health, Bethesda, MD, USA) and mouse anti-PDGF-
viously reported in detail [22, 23]. Wistar rats subcutane- B chain (PGF-007; 1:100, generous gift from Mochida
ously injected with adjuvant alone were used as the Pharmaceutical, Tokyo, Japan) were used, respectively.
controls. Five rats were sacrificed at each time point on The secondary antibodies employed were as follows:
day 21, 28, 35, 42, 49, and 56, and kidney tissues were Rhodamine-conjugated anti-rabbit IgG and anti-mouse
collected from each rat. One whole kidney from each IgG (1:500; Chemicon International) and FITC-conju-
rat was used for RNA extraction. Tissues of the other gated anti-rabbit IgG and anti-mouse IgG (1:500; Ameri-
kidney were fixed in 4% phosphate saline-buffered para- can Qualex, San Clemente, CA, USA). These dual-stained
formaldehyde overnight. One part of each tissue speci- sections were analyzed with a confocal microscope
men was processed into paraffin blocks for histopathol- (MRC600; Bio-Rad Laboratories, Hercules, CA, USA).
ogy and immunohistochemistry analyses. Another part All of the secondary antibodies had been isolated by
of the tissue samples was rinsed in serial concentrations immunoaffinity chromatography and absorbed for dual
of sucrose and then snap frozen for immunofluorescence labeling. Control measures included omitting the pri-
and in situ hybridization (ISH). The rest of the fixed mary antibody and substituting the primary antibody
tissue was processed for IEM as described later. with normal IgG from the same animal.
Immunohistochemistry and morphometric analysis Immunoelectron microscopy
Sections were cut 4 m in thickness from the paraffin A postembedding immunogold technique was used
blocks and processed for hematoxylin and eosin (HE) to demonstrate the ultrastructural features of -SMA
staining and the indirect immunoperoxidase method de- FbLCs. After overnight fixation with 4% paraformalde-
scribed in detail previously [22, 23]. Mouse anti--SMA hyde, the tissues were dehydrated in 70% ethanol at 4C
(1:500; Sigma, St. Louis, MO, USA), anti-VIM (1:500; for 10 minutes, 95% ethanol at room temperature (RT)
Dako Japan, Kyoto, Japan), anti-rat monocytes (ED-1; for 10 minutes, and 100% ethanol at RT for 15 minutes,
1:200; Chemicon International, Temecula, CA, USA), followed by three repetitions of the final step. The tissue
and rabbit anti-rat tail Col l (1:400) [14] were applied was then embedded in LR White resin (London Resin,
as primary antibodies. Twenty cortical fields at 100 Berkshire, UK). Ultrathin sections were captured on
magnification were assessed quantitatively in each immu- uncoated nickel grids and then mounted consecutively
nostained section using a color image computer analyzer on top of a drop of the following reagents: (1) 0.01 mol/L
(Mac SCOPE, version 2.5; Mitani Corp., Hukui, Japan). phosphate-buffered saline (PBS; pH 7.4) six times for
All glomeruli and vessels were subtracted from a given
one minute at 4C; (2) 5% bovine serum albumin in 0.01
field, yielding a target area of tubulointerstitium. Intersti-
mol/L PBS (pH 7.4) for 15 minutes at RT; (3) mousetial ED-1 monocyte infiltration was expressed as the
anti--SMA (1:500) overnight at 4C; (4) same as stepmean cell number in the tubulointerstitium. Interstitial
1; (5) gold-labeled anti-mouse IgG (AutoProbe; diame-
-SMA FbLCs and tubulointerstitial VIM cells, and
ter 15 nm; Amersham Pharmacia Biotech, Uppsala, Swe-interstitial Col I accumulation were expressed as the
den) for 30 minutes at RT; (6) same as step 1; (7) distilledpercentage of positive area in the tubulointerstitium.
water six times for one minute at RT; and (8) 2% glutar-Dual immunofluorescence (DIF) was performed on 4
aldehyde for 10 minutes at RT. After washing with dis-m cryostat sections. The primary antibodies employed
tilled water and drying, the sections were double stainedwere as follows: FITC-conjugated mouse anti--SMA
with uranyl acetate and lead and then examined using(1:500; Sigma), anti-VIM (1:500), anti-MYS (1:100; Santa
an electron microscope. Control experiments were per-Cruz Biotechnology, Santa Cruz, CA, USA), rabbit anti-
formed with the omission of the primary antibodies, butDSM (1:200, Monosan, Uden, Netherlands), and anti-
with the application of secondary antibodies.ecto-5-nucleotidase (5-NT; a marker for type I intersti-
tial cells; 1:1000, generous gift from B. Kaissling, Basel
In situ hybridization
University, Basel, Switzerland [7]). To label cells produc-
In situ hybridization was performed by the methoding tissue inhibitor of metalloproteinase-1 (TIMP-1) and
described in detail previously [22, 23], using cRNAproliferating cells positive for proliferating cell nuclear
probes generated from cDNA clones encoding rat 1(I)antigen (PCNA), mouse anti–TIMP-1 (1:100; Oncogene
procollagen (generous gift from Y. Yamada, NationalResearch Products, Cambridge, MA, USA) and Phyco-
Institutes of Health). Hybridization and the final washerythrin-conjugated mouse anti-PCNA (1:100; Antigenix
were carried out at 55C overnight with 2  standardAmerica, Franklin Square, NY, USA) were used, respec-
saline citrate (SSC) for 30 minutes at 50C, respectively.tively. To label cells secreting transforming growth
Using these sections, DIF with anti--SMA and anti-factor-1 (TGF-1) and platelet-derived growth fac-
VIM steps were carried out as described previously intor-B (PDGF-B) chain, rabbit anti-TGF-1 (LC1-30;
1:500, generous gift from J. Kopp, National Institutes of this article.
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Fig. 1. Quantitative analysis of the morphological parameters in the renal cortex of Goodpasture syndrome (GPS) rats. (A) Interstitial infiltration
of ED-1 monocytes. The number of ED-1 monocytes in the interstitium gradually increased, peaking at day 35, and then decreasing thereafter.
(B) Interstitial -smooth muscle actin (-SMA) fibroblast-like cells (FbLCs). The relative area of -SMA FbLCs in the interstitium gradually
increased, peaking at day 49. (C ) Tubulointerstitial vimentin (VIM) cells. The relative area of VIM tubular epithelium and interstitial FbLCs
gradually increased until it reached a peak at day 49. (D) Interstitial accumulation of Col I. Finally, the relative area of Col I accumulation in
GPS rats gradually increased in a time-dependent fashion and reached a peak at day 56. *P  0.05.
RNase protection assay tion and ethanol precipitation had been performed, the
hybridized probes protected from RNase digestion wereTotal RNA was extracted from the homogenates of
denatured at 85C for three minutes and electrophoresedwhole kidneys with TRIzol (GIBCO BRL, Grand Is-
on 6% polyacrylamide gels. The dried gels were exposedland, NY, USA) according to the manufacturer’s instruc-
to x-ray films for 6 to 24 hours in order to detect signals.tions. Ten micrograms of RNA were hybridized with 32P-
For quantifying each mRNA’s expression, the autoradio-labeled antisense cRNA probes (1  105 counts/min) in
graph bands were analyzed by computerized densitome-combination with GAPDH antisense probes, synthe-
try using Mac SCOPE. Data are presented as the ratiosized by in vitro transcription using the linearized tem-
of specific mRNA to GAPDH mRNA (to equalize theplates, at 45C overnight. Unhybridized probes were di-
quantity of RNA within each sample).gested with RNase A (0.3 mg/mL; Sigma) and RNase
T1 (30 U/mL; GIBCO BRL) at 30C for one hour. The
Statistical analysiscRNA probes were generated from cDNA fragments
Values are presented as means	 SE. Statistical differ-encoding rat 1(I) procollagen and rat TIMP-1 (generous
ences between the groups were evaluated by analyses ofgift from A. Okada, Tokyo University, Tokyo, Japan).
variance, followed by Duncan’s multiple range test, withThe RNases were inactivated via proteinase K treatment
at 37C for 30 minutes. After phenol-chloroform extrac- P  0.05 used as the requirement for significance.
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Fig. 2. Immunohistochemistry of the kidneys of GPS rats. (a) ED-1 monocytes in the kidney
of day 35 GPS rats. A number of ED-1 monocytes accumulated in the peritubular interstitium
(arrowheads; DAB, 150). (b) -smooth muscle actin (-SMA) fibroblast-like cells (FbLCs)
in the kidneys of day 49 GPS rats. A number of-SMA FbLCs were observed in the periglomeru-
lar and peritubular interstitium (arrows). Some of the glomerular mesangial cells were positive
for -SMA (DAB, 150). (c) Vimentin (VIM) tubular epithelium and FbLCs in the kidney
of day 49 GPS rats. Significant areas of tubular epithelium became VIM (arrows), and a number
of VIM FbLCs were found in the peritubular interstitium (arrowheads; DAB, 150). (d)
Collagen 1 (Col l) accumulation in the kidneys of day 56 GPS rats. There was significant accumula-
tion of Col l in the peritubular and perivascular interstitium (arrows) as well as the arteriolar
wall (DAB, 150).
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Fig. 3. RNase protection assay (RPA of the kidneys of GPS rats. (A) Expression of 1(I) procollagen mRNA. (B) Quantitative densitometric
analysis of (A). Expression of 1(I) procollagen mRNA gradually increased to a peak around day 42 to 49 and then decreased (*P  0.05). (C )
Expression of TIMP-1 mRNA. (D) Quantitative densitometric analysis of (C). Expression of TIMP-1 mRNA gradually increased until it reached
a peak around day 35 to 42 and then gradually decreased (*P  0.05). Each blot is representative of three independent experiments, and the
densitometric data were obtained from these three blots.
RESULTS a time-dependent fashion until it reached a peak around
day 42 to 49 (Fig. 3 a, b), which preceded the prominentCharacterization of renal interstitial fibrosis
renal fibrosis with peak accumulation of Col I proteinin GPS rats
at day 56 (Fig. 1d). In Figure 2d, it can be seen that some
As shown in Figure 1, the peak of interstitial infiltra- of the arteriolar wall was positive for Col l. This implies
tion by monocytes at day 35 preceded the increases in that vascular smooth muscle cells produce increased lev-
the number of -SMA FbLCs, the amount of VIM els of Col l in the nephritic kidney [24]. Similarly, the
tubular epithelium, and the number of VIM FbLCs expression of TIMP-1 mRNA increased until it reached
at approximately day 42 to 49 (Fig. 2 a–c). Thereafter, a peak around day 35 to day 42 (Fig. 3 c, d), possibly
accumulation of Col I became significant in the intersti- contributing to enhanced accumulation of interstitial col-
tium of the renal cortex of GPS rats at day 56 (Fig. 2d). The lagens in GPS rats. From day 56, the GPS rats began to
die, most likely from end-stage renal failure.expression of 1(I) procollagen mRNA was increased in

Fig. 5. Type I collagen- and TIMP-1-producing FbLCs in the kidneys of 49-day GPS rats. (a) In situ hybridization (ISH) for 1(I) procollagen
mRNA. (BCIP/NT, 400). (b) Dual immunofluorescence (DIF) for -SMA (in green) and VIM (in red) on the same section of (a) (FITC and
rhodamine, 400). Peritubular FbLCs producing 1(I) procollagen (arrows) in Figure 5a were negative for -SMA and VIM in (b). (c) TIMP-1
(in red) and VIM (in green). Most of the VIM tubular epithelium and some of the VIM FbLCs were simultaneously positive for TIMP-1,
yielding yellow color (arrows). (FITC and rhodamine, 200). (d) TIMP-1 (in red) and -SMA (in green). -SMA FbLCs in green were negative
for TIMP-1, shown in red (FITC & Rhodamine, 200).
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Fig. 4. Phenotypic/functional marker expression in interstitial FbLCs in the renal cortex of day 49 GPS rats. (a) -Smooth muscle actin (-SMA)
(in green) and desmin (DSM) (in red). Most of the -SMA FbLCs in green were simultaneously positive for DSM in red, resulting in a number
of FbLCs that ultimately appeared yellow (arrows; FITC and rhodamine, 400). (b) -SMA (in green) and VIM (in red). They were clearly
different from each other, since there were no cells in yellow, indicating no dual-positive FbLCs (FITC and rhodamine, 400). (c) -SMA (in
green) and myosin heavy chain (MYS) (in red). There were no MYS FbLCs in red in the interstitium, and only vascular wall cells were doubly
positive for -SMA and MYS (arrow; FITC and rhodamine, 400). (d) Immunoelectron microscopic observation of -SMA FbLCs. -SMA
FbLCs were observed in the peritubular interstitium of the renal cortex. -SMA microfilaments (arrows) distributed in the perimembranous cytoplasm.
There were no well-developed rough endoplasmic reticulum (rER) and actin-stress fibers within those cells (15 nm gold particle, 4000). (e) TGF-1
(in green) and VIM (in red). Some of the VIM tubular epithelium and the VIM FbLCs were simultaneously positive for TGF-1, yielding
yellow color (arrows; FITC and rhodamine, 200). ( f ) PDGF-B chain (in red) and VIM (in green). Some tubular epithelium are shown in yellow
(arrows), suggesting that some of the VIM tubular epithelium were positive for both PDGF-B chain and VIM (FITC and rhodamine, 200).
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Fig. 4 (Continued).
Table 1. Dual immunofluorescence analysis of phenotypic markers and erythropoietin synthesis [7]. In addition, no intersti-
tial FbLCs, but some glomerular cells, were positive for-SMA VIM DSM MYS TGF-1 PDGF-B
PCNA in the kidney of day 49 GPS rats (data not shown),-SMA VWCsa FbLCs VWCs (
) (
)
VWCs suggesting that FbLCs were productive but not prolifera-
VIM VWCsa VWCsa TECs TECsa tive around day 49 in this model.
FbLCsa





) vealed that the rough endoplasmic reticulum (rER) and
TGF-1 NC actin stress-fibers were not well developed in the -SMA
PDGF-B
FbLCs within the renal cortex (Fig. 4d), which was
Abbreviations are: -SMA, -smooth muscle actin; VIM, vimentin; DSM, clearly in contrast to typical myoFbs observed in the skindesmin; MYS, myosin heavy chain; TGF-1, transforming growth factor-1;
PDGF-B, platelet-derived growth factor B chain; FbLCs, interstitial fibroblast- granulation tissue [9, 10].
like cells; TECs, tubular epithelial cells; VWCs, vascular wall cells; (
), no dual Para/autocrine function. A summary of cytokine se-positive cells; NC, not checked.
a Positive in occasional cells cretion by FbLCs is also shown in Table 1. TGF-1 is
positive in some VIM tubular epithelium and VIM
FbLCs (Fig. 4e). In addition, PDGF-B chains were also
present in some VIM tubular epithelium (Fig. 4f).Characterization of interstitial FbLCs
Extracellular matrix metabolism. RNase protectionin the nephritic kidney
assay (RPA) revealed that 1(I) procollagen mRNA was
Phenotypic marker expression. Given that day 49 GPS significantly expressed in the kidneys of day 49 GPS rats
rats demonstrated significantly elevated numbers of (Fig. 3 a, b). However, ISH/DIF demonstrated that neither
-SMA and VIM FbLCs and maximal expression of -SMA nor VIM FbLCs predominantly expressed
1(I) procollagen mRNA, renal tissues of day 49 GPS 1(I) procollagen mRNA in those nephritic kidneys (Fig.
rats were selected and evaluated in detail. Table 1 sum- 5 a, b), and therefore, the principle FbLCs responsible
marizes the phenotypic marker expression of interstitial for Col I production remains unidentified. TIMP-1 gene
FbLCs in the renal cortex of day 49 GPS rats. There expression was also found in the kidneys of those GPS
were a number of -SMA FbLCs, most of which were rats (Fig. 3 c, d), and TIMP-1 protein was positive in
simultaneously positive for DSM (Fig. 4a). Most of the some of the VIM tubular epithelium and FbLCs, but
VIM FbLCs were negative for the other mesenchymal was negative in the -SMA FbLCs (Fig. 5 c, d).
markers examined, including -SMA (Fig. 4b). MYS
expression was not seen in any interstitial FbLCs, but
DISCUSSIONwithin the vascular wall cells (Fig. 4c). The expression
of 5-NT was not seen in any interstitial FbLCs (data not This study found that -SMA FbLCs are unlikely to
be involved in Col I synthesis; however, we were notshown), suggesting abnormal intrarenal hemodynamics
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able to determine which type of FbLCs were responsible despite the progression of renal fibrosis [40]. Further
studies are needed in order to prove their direct contribu-for it. In contrast, based on the colocalization results,
VIM FbLCs were demonstrated to produce TGF-1 tion to fibrogenesis in the nephritic kidney.
Either Col I or-SMA colocalizes in granulation tissueand TIMP-1, and thus indirectly contribute to renal fibro-
genesis. Recently, a growing number of nephrologists have myoFbs [9, 10], but not in renal FbLCs (Figs. 5 a, b). No
common sequence indicating the putative FbLC-specificbecome interested in renal fibrosis, given that the extent
of renal fibrosis is the best predictor of functional progno- enhancer element was identified between the 5 flanking
regions of the 1(I) procollagen [41, 42] and-SMA genessis [5, 6]. Via various elegant studies concerning myoFbs
in skin granulation tissues, in which VIM/-SMA [43, 44]. Okada et al found a cis-acting element for FbLC-
specific transcription of Fb-specific protein-1 (FSP1) that(VA-type) myoFbs with well-developed rER and actin-
stress fibers have been demonstrated to synthesize inter- had been cloned as a murine FbLC-specific protein and
named this element the Fb transcription site-1 (FTS-1)stitial ECM molecules and TGF-1, and to retract sur-
rounding tissues [9, 10, 25–28], all -SMA FbLCs resid- [45]. A search of the genomic database with the FTS-1
sequence identified identical sites in the early promotering within fibrotic areas of different organs have been
presumed to engage in these same activities. Thus, renal regions of the 1(I) procollagen and -SMA genes [45],
which implies that both of them can be expressed in-SMA FbLCs also have been thought to play an essen-
tial role in renal fibrosis in the same scenario [1–4, 29]. FSP1 FbLCs. However, distributions of FSP1 and
-SMA in some murine models of renal disease wereHowever, such -SMA FbLCs, presumed to be renal
myoFbs, have never been characterized in detail. There clearly different [36], and those of Col I and -SMA in
GPS rat kidney also were found to be different in thishave been a few studies investigating Col I-producing
FbLCs in the kidney. In those studies, perivascular ad- study. Thus, FTS-1 seems unlikely to be strong enough
alone in the promoter region of a given gene to governventitial cells in anti-GBM nephritis [30], and peritubular
interstitial cells in acute puromycin aminonucleoside ne- its expression in a discrete type of FbLCs.
In the normal kidney, VIM FbLCs have been tradi-phrosis [31] and obstructive nephropathy [32] were found
to produce Col I. However, the phenotypes of those tionally recognized as typical Fbs similar to dermal VIM
FbLCs [8, 10]. In the case of a diseased kidney, we foundcells were not determined. In contrast to liver, lung, and
pancreas fibrosis, where -SMA FbLCs were confirmed that the renal interstitial VIM FbLCs produced not
Col I but TGF-1 and TIMP-1, promoting renal fibro-to produce Col I [33–35], we demonstrated in this study
that -SMA FbLCs were unlikely to act as the main genesis. These findings are compatible with the findings
by Yamamoto, Noble and Border that sustained expres-producers of Col I in the kidney, at least during the peak
of the fibrogenesis process in the kidneys of GPS rats. sion of TGF-1 by the VIM FbLCs underlies the devel-
opment of renal fibrosis in the progressive form of anti–Less active Col I production by those renal interstitial
-SMA FbLCs was consistent with the findings by IEM Thy-1 nephritis in rats [21]. As further supporting
evidence, Isaka et al reported their success in transfectionthat they were not equipped with well-developed rER.
In addition, most of these -SMA FbLCs were found of TGF-1 antisense oligodeoxynucleotides into renal
interstitial FbLCs, which were likely to be VIM, andto be negative for bundles of actin-stress fibers and TGF-
1, and to bear intermediate filaments of DSM instead blocking the progression of renal fibrosis in rat obstruc-
tive nephropathy [46].of VIM in this study, all of which are apparent differences
between renal -SMA FbLCs and granulation tissue As indicated in the literature, VIM positivity in renal
tubular epithelium is a feature of regeneration and themyoFbs [9, 10]. Therefore, we should reconsider whether
renal interstitial -SMA FbLCs are true myoFbs ac- renal tubular epithelium is thought to control, at least
partially, the phenotype of FbLCs and play an importantcording to their original definition [9, 10]. Nevertheless,
a contribution of those -SMA FbLCs to renal fibro- role in renal fibrosis [2–4, 47–49]. Previously, we reported
that tubular epithelium produced chemoattractants forgenesis cannot be excluded because some of them were
positive for HSP47, a collagen-binding chaperone [36, 37], monocytes (for example, monocyte chemoattractant pro-
tein-1 and osteopontin) that enrolled monocytes into thesuggesting their involvement in collagen synthesis, and
some were also found to produce Col III [19, 20]. In peritubular interstitium in GPS rats, giving rise to the
early interstitial alterations seen prior to renal fibrosisfact, the presence of -SMA FbLCs in the interstitium
was reported to correlate with renal fibrosis and the [22, 23]. In addition to such chemoattractants, fibrogenic
cytokines, for example, TGF-1 and PDGF-BB, andworsening of renal function in several renal diseases,
that is, IgA nephropathy [38] and diabetic nephropathy TIMP-1 were produced exclusively by the tubular epithe-
lium in this model, contributing to renal fibrogenesis. In[39]. However, in contrast, Morrissey and Klahr recently
reported that a decrease in the number of -SMA fact, TIMP-1 mRNA expression in the nephritic kidney
increased prior to the increase in 1(I) procollagenFbLCs in the renal interstitium resulted from angiotensin
type 2 receptor blockade in rat obstructive nephropathy mRNA in this model, possibly accelerating collagen de-
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PBS, phosphate-buffered saline; PCNA, proliferating cell nuclear anti-position. This may be of greater importance than pre-
gen; PDGF, platelet-derived growth factor; rER, rough endoplasmic
viously believed, since decreased collagen degradation reticulum; RPA, RNase protection assay; RT, room temperature;
TGF-, transforming growth factor-; TIMP-1, tissue inhibitor of met-is thought to be the most significant metabolic abnormal-
alloproteinase-1; VIM, vimentin.ity in some renal fibrosis models [2, 50].
We demonstrated that the interstitium in nephritic
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